RPG Life Sciences Limited (BOM: 532983)
India
· Delayed Price · Currency is INR
2,163.20
0.00 (0.00%)
At close: Dec 24, 2024
RPG Life Sciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 23, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Market Capitalization | 35,413 | 25,279 | 11,585 | 9,269 | 6,407 | 2,808 | Upgrade
|
Market Cap Growth | 82.02% | 118.21% | 24.98% | 44.67% | 128.15% | -31.49% | Upgrade
|
Enterprise Value | 34,153 | 24,260 | 10,780 | 8,672 | 6,386 | 2,913 | Upgrade
|
Last Close Price | 2140.70 | 1514.90 | 680.65 | 538.31 | 367.42 | 161.79 | Upgrade
|
PE Ratio | 50.12 | 28.84 | 17.13 | 18.01 | 16.02 | 9.68 | Upgrade
|
PS Ratio | 6.30 | 4.34 | 2.26 | 2.11 | 1.65 | 0.75 | Upgrade
|
PB Ratio | 10.26 | 6.74 | 3.77 | 3.62 | 2.96 | 1.59 | Upgrade
|
P/TBV Ratio | 11.01 | 7.29 | 4.22 | 4.19 | 3.57 | 2.08 | Upgrade
|
P/FCF Ratio | 87.74 | 100.59 | 19.94 | 22.72 | 12.88 | 7.12 | Upgrade
|
P/OCF Ratio | 36.58 | 26.79 | 12.76 | 14.32 | 11.00 | 5.60 | Upgrade
|
EV/Sales Ratio | 5.52 | 4.17 | 2.10 | 1.97 | 1.64 | 0.78 | Upgrade
|
EV/EBITDA Ratio | 23.88 | 19.08 | 10.53 | 10.25 | 9.34 | 5.17 | Upgrade
|
EV/EBIT Ratio | 27.46 | 21.84 | 12.24 | 12.26 | 11.90 | 6.78 | Upgrade
|
EV/FCF Ratio | 76.96 | 96.54 | 18.56 | 21.26 | 12.83 | 7.39 | Upgrade
|
Debt / Equity Ratio | - | - | 0.00 | 0.00 | 0.01 | 0.07 | Upgrade
|
Debt / EBITDA Ratio | - | - | 0.00 | 0.01 | 0.03 | 0.20 | Upgrade
|
Debt / FCF Ratio | - | - | 0.00 | 0.02 | 0.04 | 0.30 | Upgrade
|
Asset Turnover | 1.22 | 1.25 | 1.34 | 1.36 | 1.37 | 1.45 | Upgrade
|
Inventory Turnover | 2.04 | 1.93 | 1.97 | 2.08 | 2.58 | 3.01 | Upgrade
|
Quick Ratio | 1.26 | 1.35 | 1.50 | 1.34 | 1.28 | 0.82 | Upgrade
|
Current Ratio | 2.04 | 2.28 | 2.57 | 2.58 | 2.21 | 1.52 | Upgrade
|
Return on Equity (ROE) | 19.76% | 25.69% | 24.01% | 21.80% | 20.36% | 17.21% | Upgrade
|
Return on Assets (ROA) | 15.31% | 14.89% | 14.41% | 13.65% | 11.77% | 10.36% | Upgrade
|
Return on Capital (ROIC) | 21.74% | 20.35% | 19.51% | 18.61% | 16.49% | 13.93% | Upgrade
|
Earnings Yield | 2.00% | 3.47% | 5.84% | 5.55% | 6.24% | 10.33% | Upgrade
|
FCF Yield | 1.14% | 0.99% | 5.01% | 4.40% | 7.77% | 14.04% | Upgrade
|
Dividend Yield | 0.00% | 1.06% | 1.76% | 1.78% | 1.96% | 2.47% | Upgrade
|
Payout Ratio | 37.45% | 22.64% | 23.48% | 23.14% | - | 36.50% | Upgrade
|
Buyback Yield / Dilution | 0.01% | - | - | - | - | - | Upgrade
|
Total Shareholder Return | 0.01% | 1.06% | 1.76% | 1.78% | 1.96% | 2.47% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.